Perampanel during pregnancy: Description of four cases
Perampanel (PER) is approved in Italy as an adjunctive treatment for focal-onset seizures (FOS) and generalized tonic-clonic seizures (GTCs), and it could be an alternative to valproate in young women diagnosed with idiopathic generalized epilepsy. Nevertheless, clinical data about the outcome of pr...
Main Authors: | A.M. Alicino, G. Falcicchio, G. Boero, G. Santarcangelo, T. Francavilla, M. Trojano, A. La Neve |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-01-01
|
Series: | Epilepsy & Behavior Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589986421000642 |
Similar Items
-
Efficacy and tolerability of perampanel: a Chinese real-world observational study in epilepsy
by: Ya Zeng, et al.
Published: (2024-01-01) -
Initial therapeutic target attainment of perampanel in pediatric patients with epilepsy
by: Lingyan Yu, et al.
Published: (2023-11-01) -
Efficacy and Tolerability of Perampanel as Adjunctive Therapy in Chinese Patients With Focal-Onset Seizures: An Observational, Prospective Study
by: Ranran Zhang, et al.
Published: (2021-08-01) -
Perampanel’s forgiveness factor in a variable medication adherence paradigm in a rat model of chronic epilepsy
by: Michelle Guignet, et al.
Published: (2023-09-01) -
An Evidence-Based Review On The Use Of Perampanel For The Treatment Of Focal-Onset Seizures In Pediatric Patients
by: Dozières-Puyravel B, et al.
Published: (2019-09-01)